Hydrocodone Bitartrate/Pseudoephedrine Hydrochloride

酒石酸氢可酮/盐酸伪麻黄碱

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHydrocodone Bitartrate/Pseudoephedrine Hydrochloride
Drug Alias NamePseudoephedrine Hydrochloride/Hydrocodone Bitartrate盐酸伪麻黄碱/酒石酸氢可酮hydrocodone bitartrate and pseudoephedrine hydrochloridepseudoephedrine hydrochloride and hydrocodone bitartrateRezira
ClassificationSmall molecules
Mechanisms of ActionAlpha adrenergic receptor agonistsOpioid receptors agonists
TargetsOpioid receptorsAlpha adrenergic receptor
Therapy Area/IndicationsCoughNasal Obstruction
Global Approved IndicationsCoughNasal Obstruction
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2011/06/08
Country/TerritoryUnited States
CombinationsYes Pseudoephedrine HydrochlorideHydrocodone Bitartrate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesCypress Pharmaceutical, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPersion Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsCoughNasal Obstruction

Other Information

ATC CodeN/A
Related LinksN/A